Journal
AMERICAN JOURNAL OF MEDICAL GENETICS PART A
Volume 146A, Issue 21, Pages 2794-2798Publisher
WILEY-BLACKWELL
DOI: 10.1002/ajmg.a.32384
Keywords
anophthalmia; micorphthalmia; SOX2 anophthalmia syndrome
Categories
Funding
- Albert Einstein Society of the Albert Einstein Healthcare Network
- Albert B.Millett Memorial Fund
- Mellon Mid-Atlantic Charitable Trust
- The Rae S. Uber Trust
- A Mellon Mid-Atlantic Charitable Trust
- NIH [RO1 EY014685, 2PEY01583]
- Research To Prevent Blindness, Inc.
- The Mabel E. Leslie Endowment Funds
- NIH/NCRR [Mol-RR-000240]
Ask authors/readers for more resources
The SOX2 anophthalmia syndrome is emergin as a clinically recognizable disorder that has been identified in 10-15% of individuals with bilateral anophthalmia or microphthalmia. In this report, we describe two sisters with bilateral anophthalmia/microphthalmia, brain anomalies and a novel heterozygous SOX2 gene single-base pair nucleotide deletion, c.551delC, which predicts p.Pro184ArgfsX19. The hypothetical protein product is predicted to lead to haploinsufficient SOX2 function. Mosaicism for this mutation in the SOX2 gene was also identified in their clinically unaffected mother in peripheral blood DNA. Thus it cannot be assumed that all SOX2 mutations in individuals with anophthalmia/microphthalmia are de novo. Testing of parents is indicated when a SOX2 mutation is identified in a proband. (c) 2008 Wiley-Liss, Inc.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available